Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Viavi Solutions
VIAV
$2.69B
| $5.54M | ﹤0.01% |
488,600
| – | – |
|
1252
Mueller Water Products
MWA
$3.91B
| $5.52M | ﹤0.01% |
340,200
+3,800
| +1% | +$61.7K |
|
1253
Arbor Realty Trust
ABR
$2.25B
| $5.51M | ﹤0.01% |
371,951
+38,700
| +12% | +$574K |
|
1254
Community Bank
CBU
$3.11B
| $5.5M | ﹤0.01% |
117,400
+1,500
| +1% | +$70.3K |
|
|
SAGE
1255
DELISTED
Sage Therapeutics
SAGE
| $5.5M | ﹤0.01% |
117,000
+1,500
| +1% | +$70.5K |
|
1256
Boot Barn
BOOT
$5.4B
| $5.5M | ﹤0.01% |
64,900
+600
| +0.9% | +$50.8K |
|
1257
Highwoods Properties
HIW
$3.5B
| $5.49M | ﹤0.01% |
229,602
+2,600
| +1% | +$62.2K |
|
|
AXNX
1258
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.49M | ﹤0.01% |
108,700
+23,200
| +27% | +$1.17M |
|
|
DNB
1259
DELISTED
Dun & Bradstreet
DNB
| $5.49M | ﹤0.01% |
474,100
+50,900
| +12% | +$589K |
|
1260
Progress Software
PRGS
$1.81B
| $5.47M | ﹤0.01% |
94,200
+1,300
| +1% | +$75.5K |
|
1261
Upstart Holdings
UPST
$6.07B
| $5.47M | ﹤0.01% |
152,800
-6,300
| -4% | -$226K |
|
1262
ACI Worldwide
ACIW
$5.18B
| $5.45M | ﹤0.01% |
235,400
+5,000
| +2% | +$116K |
|
1263
Innospec
IOSP
$2.05B
| $5.45M | ﹤0.01% |
54,303
+900
| +2% | +$90.4K |
|
1264
Walker & Dunlop
WD
$2.93B
| $5.45M | ﹤0.01% |
68,900
+1,200
| +2% | +$94.9K |
|
1265
Axsome Therapeutics
AXSM
$5.91B
| $5.45M | ﹤0.01% |
75,800
+5,500
| +8% | +$395K |
|
1266
Patterson-UTI
PTEN
$2.13B
| $5.43M | ﹤0.01% |
453,300
-14,600
| -3% | -$175K |
|
1267
Northern Oil and Gas
NOG
$2.48B
| $5.42M | ﹤0.01% |
158,000
+15,100
| +11% | +$518K |
|
1268
SITE Centers
SITC
$463M
| $5.42M | ﹤0.01% |
525,646
-3,460
| -0.7% | -$35.7K |
|
1269
Texas Capital Bancshares
TCBI
$3.98B
| $5.41M | ﹤0.01% |
105,050
-2,600
| -2% | -$134K |
|
1270
Freshworks
FRSH
$3.63B
| $5.4M | ﹤0.01% |
307,300
-5,700
| -2% | -$100K |
|
1271
International Bancshares
IBOC
$4.39B
| $5.38M | ﹤0.01% |
121,700
+1,000
| +0.8% | +$44.2K |
|
1272
ChargePoint
CHPT
$242M
| $5.37M | ﹤0.01% |
30,525
+6,680
| +28% | +$1.17M |
|
|
RETA
1273
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.34M | ﹤0.01% |
52,400
-5,800
| -10% | -$591K |
|
1274
Quaker Houghton
KWR
$2.46B
| $5.34M | ﹤0.01% |
27,400
+300
| +1% | +$58.5K |
|
1275
Associated Banc-Corp
ASB
$4.35B
| $5.33M | ﹤0.01% |
328,440
+4,000
| +1% | +$64.9K |
|